JP2022541938A - 選択的エストロゲン受容体分解剤 - Google Patents

選択的エストロゲン受容体分解剤 Download PDF

Info

Publication number
JP2022541938A
JP2022541938A JP2022504655A JP2022504655A JP2022541938A JP 2022541938 A JP2022541938 A JP 2022541938A JP 2022504655 A JP2022504655 A JP 2022504655A JP 2022504655 A JP2022504655 A JP 2022504655A JP 2022541938 A JP2022541938 A JP 2022541938A
Authority
JP
Japan
Prior art keywords
formula
compound
cancer
less
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022504655A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022541938A5 (https=
Inventor
パル，ランジャン・クマール
サマンタ，ビスワジット
アラドヒエ，ジェイラジ・ディリプブハイ
パサック，サンディープ・パンカジクマール
プラジャパティ，カウシック・ドハンジブハイ
パンチャル，ブハベシュ・モハンブハイ
チチューリ，トリナドハ・ラオ
Original Assignee
サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド filed Critical サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド
Publication of JP2022541938A publication Critical patent/JP2022541938A/ja
Publication of JP2022541938A5 publication Critical patent/JP2022541938A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2022504655A 2019-07-22 2020-07-22 選択的エストロゲン受容体分解剤 Pending JP2022541938A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201921029554 2019-07-22
IN201921029554 2019-07-22
PCT/IB2020/056914 WO2021014386A1 (en) 2019-07-22 2020-07-22 Selective estrogen receptor degrader

Publications (2)

Publication Number Publication Date
JP2022541938A true JP2022541938A (ja) 2022-09-28
JP2022541938A5 JP2022541938A5 (https=) 2023-08-02

Family

ID=71842730

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022504655A Pending JP2022541938A (ja) 2019-07-22 2020-07-22 選択的エストロゲン受容体分解剤

Country Status (15)

Country Link
US (2) US11014915B2 (https=)
EP (1) EP4003525A1 (https=)
JP (1) JP2022541938A (https=)
KR (1) KR20220046586A (https=)
CN (1) CN114302879A (https=)
AU (1) AU2020317099A1 (https=)
BR (1) BR112022001285A2 (https=)
CA (1) CA3148592A1 (https=)
CL (1) CL2022000156A1 (https=)
IL (1) IL290036A (https=)
MX (1) MX2022001013A (https=)
PE (1) PE20221588A1 (https=)
PH (1) PH12022550182A1 (https=)
WO (1) WO2021014386A1 (https=)
ZA (1) ZA202201157B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021003440A2 (pt) * 2018-09-07 2021-05-18 Sanofi sais de 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil) pirrolidin-3-il]oxifenil]-8,9-di-hidro-7h-benzo[7]anuleno-2-carboxilato de metila e seu processo de preparação
CN114127054B (zh) 2019-07-22 2024-04-09 勃林格殷格翰国际有限公司 作为用于治疗炎性气道或纤维化疾病的自分泌运动因子(atx)调节剂的n-甲基、n-(6-(甲氧基)哒嗪-3-基)胺衍生物
KR20220046586A (ko) * 2019-07-22 2022-04-14 썬 파마 어드밴스트 리서치 컴패니 리미티드 선택적 에스트로겐 수용체 분해제
CA3243621A1 (en) * 2022-02-01 2023-08-10 Eli Lilly And Company METHODS FOR PREPARING SELECTIVE ESTROGEN RECEPTOR DEGRADING AGENTS
CN119176799B (zh) * 2024-09-19 2025-10-03 晨伫(杭州)生物科技有限责任公司 色烯衍生物及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014205136A1 (en) * 2013-06-19 2014-12-24 Seragon Pharmaceuticals, Inc. Azetidine estrogen receptor modulators and uses thereof
WO2017072792A1 (en) * 2015-10-27 2017-05-04 Sun Pharma Advanced Research Company Limited Novel heterocyclic antiestrogens

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395842A (en) 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
EP0470310B1 (en) 1990-08-09 1995-11-29 Council of Scientific and Industrial Research Novel benzopyrans and process for their production
US6060503A (en) 1991-12-02 2000-05-09 Endorecherche, Inc. Benzopyran-containing compounds and method for their use
US5407947A (en) 1993-11-05 1995-04-18 Eli Lilly And Company Methods for inhibiting bone loss using pyrolidine and piperidine substituted benzopyrans
US5389646A (en) 1993-12-30 1995-02-14 Zymogenetics, Inc. Methods for treatment and prevention of bone loss using 2,3-benzopyrans
AU8102398A (en) 1997-07-09 1999-02-08 Central Drug Research Institute (dl)-2,3-diaryl-2h-1-benzopyrans
DE10013782A1 (de) 2000-03-15 2001-10-18 Schering Ag 4-Fluoralkyl-2H-benzopyrane mit antiestrogener Wirksamkeit, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, die diese enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln
RS56042B1 (sr) 2010-06-10 2017-09-29 Seragon Pharmaceuticals Inc Modulatori estrogenih receptora i njihove upotrebe
WO2013090829A1 (en) 2011-12-14 2013-06-20 Aragon Pharmaceuticals, Inc. Estrogen receptor modulators and uses thereof
EP2791128A4 (en) 2011-12-16 2015-04-22 Olema Pharmaceuticals Inc NOVEL BENZOPYRAN COMPOUNDS, COMPOSITIONS AND USES THEREOF
WO2014203132A1 (en) 2013-06-19 2014-12-24 Olema Pharmaceuticals, Inc. Substituted benzopyran compounds, compositions and uses thereof
EA031077B1 (ru) 2013-06-19 2018-11-30 Серагон Фармасьютикалз, Инк. Модулятор рецептора эстрогена и его применения
CN103879283B (zh) * 2014-03-10 2019-01-15 浙江吉利汽车研究院有限公司 一种电动车辆
US20160175284A1 (en) * 2014-12-18 2016-06-23 Genentech, Inc. Estrogen receptor modulators and uses thereof
WO2016174551A1 (en) 2015-04-27 2016-11-03 Pfizer Inc. Anti-estrogenic compounds
US10053451B2 (en) 2015-05-26 2018-08-21 Genentech, Inc. Heterocyclic estrogen receptor modulators and uses thereof
KR20220046586A (ko) * 2019-07-22 2022-04-14 썬 파마 어드밴스트 리서치 컴패니 리미티드 선택적 에스트로겐 수용체 분해제

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014205136A1 (en) * 2013-06-19 2014-12-24 Seragon Pharmaceuticals, Inc. Azetidine estrogen receptor modulators and uses thereof
WO2017072792A1 (en) * 2015-10-27 2017-05-04 Sun Pharma Advanced Research Company Limited Novel heterocyclic antiestrogens

Also Published As

Publication number Publication date
ZA202201157B (en) 2023-07-26
CL2022000156A1 (es) 2022-11-18
WO2021014386A1 (en) 2021-01-28
PE20221588A1 (es) 2022-10-10
PH12022550182A1 (en) 2022-11-14
EP4003525A1 (en) 2022-06-01
BR112022001285A2 (pt) 2022-03-22
KR20220046586A (ko) 2022-04-14
CA3148592A1 (en) 2021-01-28
US20210024504A1 (en) 2021-01-28
US11014915B2 (en) 2021-05-25
AU2020317099A1 (en) 2022-02-24
CN114302879A (zh) 2022-04-08
IL290036A (en) 2022-03-01
US20210261534A1 (en) 2021-08-26
MX2022001013A (es) 2022-02-22

Similar Documents

Publication Publication Date Title
JP2022541938A (ja) 選択的エストロゲン受容体分解剤
JP7277424B2 (ja) テトラヒドロ－１Ｈ－ピリド［３，４－ｂ］インドール抗エストロゲン薬物
CN1181077A (zh) 苯并吡喃类化合物及其使用方法
CN107406433A (zh) 用于治疗癌症的2,3‑二苯基色烯的衍生物
CN108143728A (zh) 选择性雄激素受体调节剂在治疗乳癌中的用途
KR20160021281A (ko) 아제티딘 에스트로겐 수용체 조절제 및 이의 용도
KR20210018460A (ko) 선택적 에스트로겐 수용체 분해제
TW201710253A (zh) 抗雌激素化合物
JPH10509962A (ja) 骨粗鬆症の治療および予防におけるトリアリール−エチレン誘導体の使用方法
US7632963B2 (en) Crystal of (S)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate
EP4003996B1 (en) Estrogen receptor-modulating compounds
WO2004031125A1 (ja) スピロ化合物、それを含有する医薬組成物及び該化合物の中間体
JP5054882B2 (ja) テトラヒドロベンズフルオレン誘導体
RU2855858C2 (ru) ТЕТРАГИДРО-1H-ПИРИДО[3,4-b]ИНДОЛЬНЫЕ АНТИЭСТРОГЕННЫЕ ЛЕКАРСТВЕННЫЕ СРЕДСТВА
JP2025523065A (ja) アゾポドフィロトキシン誘導体ｓｕ０５６のエナンチオマー
WO2025255358A1 (en) Solid forms of posiphen d-tartrate and processes of preparation thereof
EP1171133B1 (en) R-hydroxynefazodone
HK40056233A (en) Tetrahydro-1h-pyrido[3,4-b]indole anti-estrogenic drugs
CN115819407A (zh) 一种Ensitrelvir类似物及其制备方法和抗新冠用途
HK40075686A (en) Estrogen receptor-modulating compounds
EA048255B1 (ru) Режим дозирования для лечения рака
HK1247195A1 (en) Derivatives of 2,3-diphenylchromene useful for the treatment of cancer
HK1009440B (en) Benzopyran-containing compounds and method for their use
HK1214532B (zh) 雌激素受體調節劑及其用途
JP2004083499A (ja) 早産防止剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230720

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230720

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230724

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240827

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250218